Eli Lilly

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Eli Lilly and other ETFs, options, and stocks.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.

CEO

David A. Ricks

CEODavid A. Ricks

Employees

43,000

Employees43,000

Headquarters

Indianapolis, Indiana

HeadquartersIndianapolis, Indiana

Founded

1876

Founded1876

Employees

43,000

Employees43,000

LLY Key Statistics

Market cap

765.27B

Market cap765.27B

Price-Earnings ratio

122.98

Price-Earnings ratio122.98

Dividend yield

0.59%

Dividend yield0.59%

Average volume

3.75M

Average volume3.75M

High today

$825.00

High today$825.00

Low today

$801.30

Low today$801.30

Open price

$810.30

Open price$810.30

Volume

4.17M

Volume4.17M

52 Week high

$966.10

52 Week high$966.10

52 Week low

$446.89

52 Week low$446.89

LLY News

Investor's Business Daily 15h

Is Eli Lilly Stock A Sell On A Second Stumble In Obesity Treatment?

Is Eli Lilly stock a sell after new rivals emerged from the woodwork with promising test results and plans for oral obesity drugs? View comments...

Benzinga 1d

Walt Disney, Eli Lilly, AST SpaceMobile, DexCom, Tesla: Why These 5 Stocks Are On Investors' Radars Today

On Thursday, major U.S. indices showed mixed results. The Dow Jones Industrial Average increased by 0.2% to 39,935.07, while the S&P 500 fell by 0.5% to 5,399.2...

Benzinga 1d

Why Eli Lilly and Company Shares Are Moving Lower On Thursday

Eli Lilly and Company LLY stock is trading lower on Thursday after Viking Therapeutics, Inc. VKTX announced the advancement of its novel treatment for obesity,...

Analyst ratings

75%

of 28 ratings

Buy

75%

Hold

21.4%

Sell

3.6%

More LLY News

Quartz 1d

An Ozempic rival is getting closer to market — and it's hurting Novo Nordisk and Eli Lilly stock

Shares of Novo Nordisk and Eli Lilly slid Thursday after San Diego-based Viking Therapeutics announced that it’s advancing an experimental weight loss drug to a...

Investor's Business Daily 2d

Viking Therapeutics Unveils Monthly Weight-Loss Shot, And Rocks Eli Lilly, Novo Nordisk

Viking Therapeutics (VKTX) stock rocketed Thursday after the company said it's exploring a monthly dose of its weight-loss drug. The news is a blow to obesity k...

CNBC 2d

Viking Therapeutics stock jumps 16% after drugmaker moves weight loss injection to late-stage trial

Shares of Viking Therapeutics jumped 16% in premarket trading Thursday after the biotech company a day earlier announced plans to advance its experimental weigh...

Seeking Alpha 2d

Viking sends Lilly, Novo lower as obesity drug enters late-stage program

Weight loss drugmakers Eli Lilly (NYSE:LLY) and Novo Nordisk (NVO) were among the notable decliners in the premarket Thursday after Viking Therapeutics (NASDAQ:...

Benzinga 3d

Novo Nordisk's Stock Dips In Pre-Market Despite Winning UK's Approval Of Weight Loss Drug: What's Going On

In Wednesday’s pre-market trading, shares of Novo Nordisk A/S NVO are witnessing a fall after the U.K.’s Medicines and Healthcare products Regulatory Agency (MH...

Benzinga 4d

AnaptysBio Investigational Arthritis Drug Might Have Better Efficacy Profile Than Eli Lilly's: Analyst

Loading... Loading... HC Wainwright analyst initiated coverage on AnaptysBio Inc ANAB, a clinical-stage biotechnology company focused on delivering immunology...

Seeking Alpha 6d

Here are Big Pharma’s leading blockbuster makers

Eli Lilly (NYSE:LLY) and AstraZeneca (NASDAQ:AZN) have emerged joint winners in a list compiled by pharma analytics firm Evaluate, ranking companies with the mo...